Ingen Technologies, Inc. Gains Product Recognition From the COPD-ALERT Support & Advocacy Group

RIVERSIDE, CA--(Marketwire - November 29, 2012) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with patented proprietary medical technology for the growing $4-Billion Respiratory Industry is pleased to announce that the Company's Smart Nasal Cannula product has been approved and endorsed by the world-renowned Chronic Obstructive Pulmonary Disease (COPD) Alert Support and Advocacy Group.

COPD-ALERT provides support for lung disease patients and takes part in a worldwide campaign for recognition of a dangerous rise in the prevalence of COPD, while actively supporting the Global Obstructive Lung Disease (GOLD) Initiative. This initiative aims to raise awareness of the increasing burden of COPD, decrease morbidity and mortality, promote further study of the condition, and implement programs to prevent COPD. COPD-ALERT is actively involved in advocacy activities on the national and local levels and is a member of the National Heart, Lung, and Blood Institute Public Interest Organizations, American Thoracic Society Public Advisory Roundtable, US COPD and International Coalitions.

Having already initiated a national distribution program with the largest distributor of home health care products and services, Ingen can now concentrate its efforts in marketing its product to the $55.0 billion US home healthcare industry. In addition to organic growth, the Company is expected to make several acquisitions to expand its product portfolio.

The Company derives its value through its innovative products, strong partnerships throughout its value chain, commercial and government supply contracts, and strong management team.

VISIT COPD-ALERT at http://copd-alert.com/

VISIT OUR WEBSITE AT: www.ingen-tech.com or FACT SHEET AT: http://ingen-tech.com/files/documents/ignt-1112.pdf

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.